King B, Soung J, Tziotzios C, Rudnicka L, Joly P, Gooderham M, Sinclair R, Anway S, Wajsbrot D, Lejeune A, Zwillich S. Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program. J of Skin [Internet]. 2023Nov.13 [cited 2024Jul.22];7(6):s291. Available from: https://jofskin.org/index.php/skin/article/view/2417